Hoffman Michael B bought 53,395 derivative units of Translational Development Acquisition Corp. at $0.79 for $42.3k on May 27, 2026

Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Chairman and CEO
Chairman and CEO
Filed May 29, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$42,278.16Shares × reported price
Shares traded
53,395Warrants
Price per share
$0.79Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
53,395Direct
Trade date
May 27, 2026Buy
Filed
May 29, 2026, 4:05 PM ET2-day reporting delay
Accession
0001104659-26-068236Code P · Transaction 94912
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

TDAC price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
TDAC · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −0.6%1w ago −1%1d ago −1%
Returns since7d −0.1%30d −0.6%90d180d1y

Footnotes in full

F1: Each warrant becomes exercisable 30 days after completion of the Issuer's initial business combination, as described in the Issuer's filings with the Securities and Exchange Commission. The warrants expire five years after completion of the Issuer's initial business combination, or earlier upon redemption or liquidation, as described in the Issuer's filings with the Securities and Exchange Commission (the "SEC") F2: The price reported in Column 8 is a weighted average price. These warrants were purchased in multiple transactions at prices ranging from $0.71 to $0.9997, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of warrants purchased at each separate price within the range set forth in this footnote. For reference, aggregate proceeds were $42,280.50 and the exact weighted average price was $0.7918438056.